Furthermore, GPx4’s dual role in cancer is evident; though it acts as a tumor suppressor by inhibiting ferroptosis in certain cell lines, its overexpression can reduce the efficacy of cancer therapies, such as cisplatin [128]. This evidence concerns the gene GPX4 and cancer.